VYOME HOLDINGS, INC. Foreign Currency Transaction Gain (Loss), before Tax
VYOME HOLDINGS, INC. (HIND) reported Foreign Currency Transaction Gain (Loss), before Tax of $61.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2025-08-14
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was $61.00K.
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-03-31 was -$12.00K.
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-12-31 was -$61.00K, a 188.41% decline year-over-year.
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-09-30 was $50.00K.
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$51.00K, a 331.82% decline from fiscal 2023.
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $22.00K.
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$141.00K, a 183.93% decline from fiscal 2021.
- VYOME HOLDINGS, INC. foreign currency transaction gain (loss), before tax for fiscal 2021 was $168.00K, a 59.02% decline from fiscal 2020.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2025-06-30 | $61.00K 10-Q · filed 2025-08-14 | $49.00K 10-Q · filed 2025-08-14 | -$12.00K derived: sum of 3 quarters · filed 2025-08-14 | $38.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | -$12.00K 10-Q · filed 2025-05-20 | -$73.00K derived: sum of 2 quarters · filed 2025-05-20 | -$23.00K derived: sum of 3 quarters · filed 2025-05-20 | -$39.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | -$11.00K derived: sum of 2 quarters · filed 2025-04-04 | -$27.00K derived: sum of 3 quarters · filed 2025-08-14 | -$51.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $50.00K 10-Q · filed 2024-11-14 | $34.00K derived: sum of 2 quarters · filed 2025-08-14 | $10.00K 10-Q · filed 2024-11-14 | $79.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | -$16.00K 10-Q · filed 2025-08-14 | -$40.00K 10-Q · filed 2025-08-14 | $29.00K derived: sum of 3 quarters · filed 2025-08-14 | -$39.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$24.00K 10-Q · filed 2025-05-20 | $45.00K derived: sum of 2 quarters · filed 2025-05-20 | -$23.00K derived: sum of 3 quarters · filed 2025-05-20 | -$23.00K derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $1.00K derived: sum of 2 quarters · filed 2025-04-04 | $1.00K derived: sum of 3 quarters · filed 2025-04-04 | $22.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | -$68.00K 10-Q · filed 2024-11-14 | -$68.00K derived: sum of 2 quarters · filed 2024-11-14 | -$47.00K 10-Q · filed 2024-11-14 | $279.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $21.00K 10-Q · filed 2024-08-14 | $347.00K derived: sum of 3 quarters · filed 2024-08-14 | $68.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $21.00K 10-Q · filed 2024-05-15 | $347.00K derived: sum of 2 quarters · filed 2024-05-15 | $68.00K derived: sum of 3 quarters · filed 2024-05-15 | -$136.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $47.00K derived: sum of 2 quarters · filed 2024-04-01 | -$157.00K derived: sum of 3 quarters · filed 2024-04-01 | -$141.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$279.00K 10-Q · filed 2023-11-09 | -$483.00K derived: sum of 2 quarters · filed 2023-11-09 | -$467.00K 10-Q · filed 2023-11-09 | -$469.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$204.00K 10-Q · filed 2023-08-07 | -$188.00K 10-Q · filed 2023-08-07 | -$190.00K derived: sum of 3 quarters · filed 2023-08-07 | -$89.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-15 | $14.00K derived: sum of 2 quarters · filed 2023-05-15 | $115.00K derived: sum of 3 quarters · filed 2023-05-15 | $216.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $99.00K derived: sum of 2 quarters · filed 2023-04-17 | $200.00K derived: sum of 3 quarters · filed 2023-04-17 | $168.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $101.00K 10-Q · filed 2022-11-14 | $202.00K derived: sum of 2 quarters · filed 2022-11-14 | $170.00K 10-Q · filed 2022-11-14 | $461.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $101.00K 10-Q · filed 2022-08-19 | $69.00K 10-Q · filed 2022-08-19 | $360.00K derived: sum of 3 quarters · filed 2022-08-19 | $488.00K derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | -$33.00K 10-Q · filed 2022-05-23 | $259.00K derived: sum of 2 quarters · filed 2022-05-23 | $387.00K derived: sum of 3 quarters · filed 2022-05-23 | $520.00K derived: sum of 4 quarters · filed 2022-05-23 |
| 2020-12-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $420.00K derived: sum of 2 quarters · filed 2022-04-08 | $553.00K derived: sum of 3 quarters · filed 2022-04-08 | $410.00K 10-K · filed 2022-04-08 |
| 2020-09-30 | $128.00K 10-Q · filed 2021-11-12 | $261.00K derived: sum of 2 quarters · filed 2021-11-12 | $118.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $133.00K 10-Q · filed 2021-08-16 | -$10.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |